Abbott Laboratories (NY:ABT)

Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly' ↗

October 15, 2025

U.S. stock futures advanced on Wednesday following Tuesday’s mixed close. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

Earnings Scheduled For October 15, 2025 ↗

October 15, 2025

Via Benzinga

Dow Jumps Over 200 Points Following Strong Bank Earnings: Investor Fear Eases Slightly, But Greed Index Remains In 'Fear' Zone ↗

October 15, 2025

Dow Jones gains, but trade tensions limit enthusiasm. Wells Fargo, Citi, JPMorgan, and Goldman Sachs beat expectations.

Via Benzinga

Topics Stocks World Trade

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Wednesday ↗

October 15, 2025

US stock futures higher, BAC, PZZA, MS expected to report earnings, ASML reports better-than-expected bookings, ABT to report earnings.

Via Benzinga

A Look Ahead: Abbott Laboratories's Earnings Forecast ↗

October 14, 2025

Via Benzinga

Abbott Laboratories (ABT) Q3 Earnings Report Preview: What To Look For

October 13, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning. Here’s what investors should know.

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

Topics Artificial Intelligence

October 13, 2025

Via Benzinga

Dow Jones Soars on Trump's Tariff Remarks, Signaling Market Volatility Amidst Trade Policy Shifts

October 13, 2025

New York, NY – October 13, 2025 – The Dow Jones Industrial Average has experienced significant upward momentum in recent months, notably jumping by hundreds of points on multiple occasions in early...

Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this week.

Topics Economy Government Stocks

A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know ↗

October 08, 2025

Via Benzinga

Retail Investors' Top Stocks With Earnings This Week: Fastenal, ASML, TSMC And More ↗

October 13, 2025

Via Benzinga

2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid

October 08, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

The time is right for buying more of these great dividend stocks.

Forecasting The Future: 12 Analyst Projections For Abbott Laboratories ↗

October 07, 2025

Via Benzinga

3 Dividend Stocks to Double Up On Right Now ↗

October 07, 2025

Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test

Topics Economy Energy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

October 06, 2025

In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test...

Via TokenRing AI

Topics Artificial Intelligence

Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience

October 02, 2025

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Topics Artificial Intelligence Economy Stocks

2 Profitable Stocks to Consider Right Now and 1 We Find Risky

October 02, 2025

This fund makes it easy to invest in the top dividend stocks.

1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now ↗

September 29, 2025

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market

Topics ETFs Stocks

September 27, 2025

Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising...

Discover Abbott Laboratories (ABT), a top Caviar Cruise screen pick. This healthcare leader excels in profitability, financial health, and cash flow, making it a strong long-term quality investment.

Topics Economy Intellectual Property

Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Investing Screen ↗

September 27, 2025

Via Chartmill

September 25, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Abbott Laboratories (ABT) is a technical breakout candidate, showing a strong uptrend and a perfect consolidation setup, suggesting a potential upward move.

Topics Retirement

Abbott Laboratories (NYSE:ABT) Presents a Technical Breakout Setup for Investors ↗

September 24, 2025

Via Chartmill

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

Don't Overlook These 2 Dividend Kings in Today's Volatile Market ↗

September 21, 2025

These businesses may be "boring," but that's a good thing in today's market.

These dividend powerhouses compound wealth through decades of consecutive increases and sustainable payout ratios.

Topics Economy Government World Trade

8 Dividend Growth Stocks Every Investor Should Consider ↗

September 19, 2025

The financial markets are currently a tempestuous sea, marked by a perplexing interplay of underlying strength and overt volatility, largely driven by the powerful forces of investor psychology. As of...

Topics Artificial Intelligence Economy

Navigating the Emotional Tides: Investor Psychology in a Volatile Market

September 22, 2025

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott's Libre 3.

Topics Artificial Intelligence Bonds Economy

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA ↗

September 18, 2025

Via Benzinga

September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?

September 15, 2025

As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation...